Related Experiment Videos
Immediate- and delayed-type contact hypersensitivity in children older than 5 years with atopic dermatitis: a pilot
A P Oranje1, D P Bruynzeel, H J Stenveld
1Subdivision of Pediatric Dermatology, University Hospital Rotterdam/Sophia Children's Hospital, The Netherlands.
Pediatric Dermatology
|September 1, 1994
Summary
Food allergy plays a limited role in children with atopic dermatitis (AD). Testing for food hypersensitivity in AD patients aged 5-15 showed inconsistent results, with limited clinical correlation.
Area of Science:
- Immunology
- Dermatology
- Pediatrics
Background:
- Atopic dermatitis (AD) is a common inflammatory skin condition in children.
- The role of food allergy in AD pathogenesis remains a subject of investigation.
- Accurate diagnostic methods for identifying relevant allergens in AD are needed.
Purpose of the Study:
- To investigate immediate- and delayed-type hypersensitivity to food and other allergens in children with AD.
- To compare various methods for detecting immediate-type hypersensitivity.
- To assess the clinical relevance of positive allergen reactions.
Main Methods:
- Prospective open study involving 30 children (aged 5-15) with persistent AD.
- Comparison of patch-scratch tests, skin application food tests, prick tests, and delayed-type patch tests for food allergens.
- Prick testing and patch testing (European standard series) for inhalant allergens.
Main Results:
- Positive reactions to food allergens were observed in a small number of patients across different tests, often without clinical symptoms.
- Delayed-type patch tests showed the fewest positive reactions to foods.
- Twenty children (67%) had positive reactions to inhalants via prick testing, with nickel being the most common allergen in patch tests.
Conclusions:
- Food allergy appears to play a limited role in children aged 5-15 with AD.
- Current hypersensitivity testing methods for food allergens in AD lack ideal predictive value.
- Dietary manipulation based on these tests may not consistently improve AD symptoms.